Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments... Show more
Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MAYZ | 29.22 | 0.13 | +0.43% |
| TrueShares Structured Outcome May ETF | |||
| TDTT | 24.15 | 0.01 | +0.04% |
| FlexShares iBoxx 3Yr Target Dur TIPS ETF | |||
| TUG | 32.17 | -0.01 | -0.03% |
| STF Tactical Growth ETF | |||
| SPXN | 59.86 | -0.05 | -0.08% |
| ProShares S&P 500® ex-Financials | |||
| BME | 36.20 | -0.17 | -0.47% |
| Blackrock Health Sciences Trust | |||
A.I.dvisor tells us that AVCNF and PRFX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCNF and PRFX's prices will move in lockstep.
| Ticker / NAME | Correlation To AVCNF | 1D Price Change % | ||
|---|---|---|---|---|
| AVCNF | 100% | +0.06% | ||
| PRFX - AVCNF | 20% Poorly correlated | -8.49% | ||
| ARSUF - AVCNF | 12% Poorly correlated | N/A | ||
| BSPK - AVCNF | 9% Poorly correlated | +44.76% | ||
| APNHY - AVCNF | 7% Poorly correlated | +4.57% | ||
| BKUH - AVCNF | 5% Poorly correlated | N/A | ||
More | ||||